Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Improving Methods for Analyzing Antimalarial Drug Efficacy Trials: Molecular Correction Based on Length-Polymorphic Markers msp-1, msp-2, and glurp.

Jones S, Kay K, Hodel EM, Chy S, Mbituyumuremyi A, Uwimana A, Menard D, Felger I, Hastings I.

Antimicrob Agents Chemother. 2019 Aug 23;63(9). pii: e00590-19. doi: 10.1128/AAC.00590-19. Print 2019 Sep.

2.

Mapping Soil-Transmitted Helminth Parasite Infection in Rwanda: Estimating Endemicity and Identifying At-Risk Populations.

Ruberanziza E, Owada K, Clark NJ, Umulisa I, Ortu G, Lancaster W, Munyaneza T, Mbituyumuremyi A, Bayisenge U, Fenwick A, Soares Magalhães RJ.

Trop Med Infect Dis. 2019 Jun 14;4(2). pii: E93. doi: 10.3390/tropicalmed4020093.

3.

Geographical distribution and prevalence of podoconiosis in Rwanda: a cross-sectional country-wide survey.

Deribe K, Mbituyumuremyi A, Cano J, Jean Bosco M, Giorgi E, Ruberanziza E, Bayisenge U, Leonard U, Bikorimana JP, Rucogoza A, Turate I, Rusanganwa A, Pigott DM, Pullan RL, Noor AM, Enquselassie F, Condo JU, Murray CJL, Brooker SJ, Hay SI, Newport MJ, Davey G.

Lancet Glob Health. 2019 May;7(5):e671-e680. doi: 10.1016/S2214-109X(19)30072-5. Epub 2019 Mar 27.

4.

Efficacy of artemether-lumefantrine versus dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria among children in Rwanda: an open-label, randomized controlled trial.

Uwimana A, Penkunas MJ, Nisingizwe MP, Warsame M, Umulisa N, Uyizeye D, Musanabaganwa C, Munyaneza T, Ntagwabira E, Hakizimana D, Muvunyi CM, Kayobotsi C, Kabera M, Murindahabi M, Mbituyumuremyi A.

Trans R Soc Trop Med Hyg. 2019 Jun 1;113(6):312-319. doi: 10.1093/trstmh/trz009.

PMID:
30892640
5.

Treatment of chronic hepatitis C virus infection in Rwanda with ledipasvir-sofosbuvir (SHARED): a single-arm trial.

Gupta N, Mbituyumuremyi A, Kabahizi J, Ntaganda F, Muvunyi CM, Shumbusho F, Musabeyezu E, Mukabatsinda C, Ntirenganya C, Van Nuil JI, Kateera F, Camus G, Damascene MJ, Nsanzimana S, Mukherjee J, Grant PM.

Lancet Gastroenterol Hepatol. 2019 Feb;4(2):119-126. doi: 10.1016/S2468-1253(18)30382-0. Epub 2018 Dec 11.

PMID:
30552056
6.

Expanding home-based management of malaria to all age groups in Rwanda: analysis of acceptability and facility-level time-series data.

Uwimana A, Penkunas MJ, Nisingizwe MP, Uyizeye D, Hakizimana D, Musanabaganwa C, Musabyimana JP, Ngwije A, Turate I, Mbituyumuremyi A, Murindahabi M, Condo J.

Trans R Soc Trop Med Hyg. 2018 Nov 1;112(11):513-521. doi: 10.1093/trstmh/try093.

PMID:
30184186
7.

Controlling hepatitis C in Rwanda: a framework for a national response.

Mbituyumuremyi A, Van Nuil JI, Umuhire J, Mugabo J, Mwumvaneza M, Makuza JD, Umutesi J, Nsanzimana S, Gupta N.

Bull World Health Organ. 2018 Jan 1;96(1):51-58. doi: 10.2471/BLT.16.183772. Epub 2017 Nov 27.

8.

Prevalence of hepatitis B and C infection in persons living with HIV enrolled in care in Rwanda.

Umutesi J, Simmons B, Makuza JD, Dushimiyimana D, Mbituyumuremyi A, Uwimana JM, Ford N, Mills EJ, Nsanzimana S.

BMC Infect Dis. 2017 May 2;17(1):315. doi: 10.1186/s12879-017-2422-9.

9.

"Waiting for DAAs": A retrospective chart review of patients with untreated hepatitis C in Rwanda.

Gupta N, Kabahizi J, Mukabatsinda C, Walker TD, Musabeyezu E, Kiromera A, Van Nuil JI, Steiner K, Mukherjee J, Nsanzimana S, Mbituyumuremyi A.

PLoS One. 2017 Mar 21;12(3):e0174148. doi: 10.1371/journal.pone.0174148. eCollection 2017.

10.

Hepatitis C virus and HIV co-infection among pregnant women in Rwanda.

Mutagoma M, Balisanga H, Sebuhoro D, Mbituyumuremyi A, Remera E, Malamba SS, Riedel DJ, Nsanzimana S.

BMC Infect Dis. 2017 Feb 22;17(1):167. doi: 10.1186/s12879-017-2269-0.

Supplemental Content

Loading ...
Support Center